A Novel Differential Predict Model Based on Matrix-Assisted Laser Ionization Time-of-Flight Mass Spectrometry and Serum Ferritin for Acute Graft-versus-Host Disease
Figure 5
The expression of peak 5931.3 Da in different grades of aGVHD. (green: non-GVHD, red: I°aGVHD, blue: II°aGVHD, and yellow: III~IV°aGVHD). ((a)~(c)) Three-dimensional ratio-intensity maps of peak 5931.3 Da in stage 1(a), stage 2(b), and stage 3(c); ((d)~(f)) bar chart of peak 5931.3 Da intensity in the four different groups, showing an increasing trend in peak 5931.3 Da in severe aGVHD patients in all 3 stages (); (g) the expression of peak 5931.3 Da in all the patients through the whole process of allo-HSCT; (h) ROC curve of the predicted probability of severe aGVHD with peak 5931.3 Da from logistic regression.
